Related Content
November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...
November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co ...
October 20, 2017 — The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea ...
September 28, 2017 — The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular Health (CCH) program is ...
April 1, 2016 — AstraZeneca confirmed that the American College of Cardiology (ACC) and American Heart Association (AHA) ...
October 2, 2015 — AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies ...
September 25, 2015 – The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial ...
September 15, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Brilinta ...
June 9, 2015 - AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial ...
April 30, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental new ...